Journal of Biopharmaceutical Statistics

Title Publication Date Language Citations
Utility of real-world evidence in biosimilar development2024/04/17English
P-values and confidence intervals for weighted log-rank tests under truncated binomial design based on clustered medical data2024/04/14English
Medical diagnostic accuracy measures: an innovative approach based on the area under predictive values curves2024/04/14English
Adaptive promising zone design for cancer immunotherapy with heterogeneous delayed treatment effect2024/04/14English
Adaptive sequential design for phase II single-arm oncology trials: an expansion of Simon’s design2024/04/15English
Bayesian design of clinical trials using the scale transformed power prior2024/04/19English
A SIMPLE WAY TO ESTIMATE THE MEDIAN TIME AND COMPARE SURVIVAL DISTRIBUTIONS IN ANALGESIC TRIALS UNDER INFORMATIVE CENSORING1999/01/11English
EFFECT OF INVESTIGATOR BIAS ON THE POWER AND LEVEL OF THE TWO-SAMPLE Z-TEST1999/05/24English
PILOT TRIAL FOR THE ASSESSMENT OF RELATIVE BIOAVAILABILITY IN GENERIC DRUG PRODUCT DEVELOPMENT: STATISTICAL POWER1999/02/23English
ESTIMATING SAMPLE SIZES FOR CONTINUOUS, BINARY, AND ORDINAL OUTCOMES IN PAIRED COMPARISONS: PRACTICAL HINTS1999/05/24English
OPTIMAL SAMPLING TIMES IN BIOEQUIVALENCE TESTS2000/02/15English
A basket trial design based on constrained hierarchical Bayesian model for latent subgroups2024/02/18English
DESIGNS FOR TESTING LACK OF FIT FOR A NONLINEAR DOSE-RESPONSE CURVE MODEL2000/02/15English
EMPIRICAL POWER FOR DISTRIBUTION-FREE TESTS OF INCOMPLETE LONGITUDINAL DATA WITH APPLICATIONS TO AIDS CLINICAL TRIALS1999/11/08English
LINEAR MIXED-EFFECT MULTIVARIATE ADAPTIVE REGRESSION SPLINES APPLIED TO NONLINEAR PHARMACOKINETICS DATA2000/09/08English
NONPARAMETRIC STEP-DOWN TEST PROCEDURES FOR FINDING MINIMUM EFFECTIVE DOSE1999/05/24English
A TWO-STAGE DOSE SELECTION STRATEGY IN PHASE I TRIALS WITH WIDE DOSE RANGES2000/09/08English
SIMPLE WAY TO ESTIMATE THE MEDIAN TIME AND COMPARE SURVIVAL DISTRIBUTIONS IN ANALGESIC TRIALS UNDER INFORMATIVE CENSORING2001/01/01English
ESTIMATION FOLLOWING EXTENSION OF A STUDY ON THE BASIS OF CONDITIONAL POWER2000/04/24English
EVALUATION OF TESTS BASED ON INDIVIDUAL VERSUS POPULATION MODELING TO COMPARE DISSOLUTION CURVES2001/01/01English
ON THE UTILITY OF THE DIRICHLET DISTRIBUTION FOR META-ANALYSIS OF CLINICAL STUDIES1999/05/24English
MODELING THE COVARIANCE STRUCTURE IN PHARMACOKINETIC CROSSOVER TRIALS1999/11/08English
STRATIFIED TESTS, STRATIFIED SLOPES, AND RANDOM EFFECTS MODELS FOR CLINICAL TRIALS WITH MISSING DATA2000/11/22English
EVALUATING OVERALL SIGNIFICANCE LEVELS IN MULTIFACTOR ANOVA1999/02/23English
NONLINEAR MODELS FOR IN VITROKILL KINETICS OF ANTIBIOTICS1999/05/24English
ROC SURFACE: A GENERALIZATION OF ROC CURVE ANALYSIS2000/04/24English
CENTER-WEIGHTING ISSUES IN MULTICENTER CLINICAL TRIALS2000/04/24English
NONINFERIORITY TESTING IN CROSSOVER TRIALS WITH CORRELATED BINARY OUTCOMES AND SMALL EVENT PROPORTIONS WITH APPLICATIONS TO THE ANALYSIS OF CONDOM FAILURE DATA1999/05/24English
Stochastic curtailment tests for phase II trial with time-to-event outcome using the concept of relative time in the case of non-proportional hazards2023/08/14English
Determining the late effect parameter in the Fleming-Harrington test using asymptotic relative efficiency in cancer immunotherapy clinical trials2023/08/10English